Sergey A. Krupenko

5.8k total citations · 1 hit paper
81 papers, 4.5k citations indexed

About

Sergey A. Krupenko is a scholar working on Molecular Biology, Rheumatology and Clinical Biochemistry. According to data from OpenAlex, Sergey A. Krupenko has authored 81 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 39 papers in Rheumatology and 24 papers in Clinical Biochemistry. Recurrent topics in Sergey A. Krupenko's work include Folate and B Vitamins Research (39 papers), Metabolism and Genetic Disorders (24 papers) and Epigenetics and DNA Methylation (16 papers). Sergey A. Krupenko is often cited by papers focused on Folate and B Vitamins Research (39 papers), Metabolism and Genetic Disorders (24 papers) and Epigenetics and DNA Methylation (16 papers). Sergey A. Krupenko collaborates with scholars based in United States, Belarus and Australia. Sergey A. Krupenko's co-authors include Natalia I. Krupenko, Natalia V. Oleinik, Lynette C. Foo, Karen S. Christopherson, Ben A. Barres, Ben Emery, Amit Kaushal, Wesley J. Thompson, Yi Xing and Jennifer Zamanian and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Sergey A. Krupenko

77 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function

2008 2.4k citations Sergey A. Krupenko et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergey A. Krupenko United States	30	2.6k	891	874	714	655	81	4.5k
Juana M. Pasquini Argentina	36	2.2k 0.8×	941 1.1×	784 0.9×	1.0k 1.4×	303 0.5×	134	4.7k
Dagmar Galter Sweden	39	2.8k 1.0×	556 0.6×	1.7k 2.0×	267 0.4×	375 0.6×	76	5.6k
James Garbern United States	39	2.2k 0.8×	755 0.8×	1.4k 1.6×	636 0.9×	183 0.3×	78	4.2k
Joyce A. Benjamins United States	34	1.6k 0.6×	714 0.8×	854 1.0×	825 1.2×	153 0.2×	102	3.5k
Jean‐Marie Matthieu Switzerland	33	1.8k 0.7×	445 0.5×	764 0.9×	919 1.3×	144 0.2×	119	4.0k
Francisca Díaz United States	34	2.9k 1.1×	569 0.6×	713 0.8×	577 0.8×	302 0.5×	63	4.4k
Ana Martín-Villalba Germany	37	3.2k 1.2×	1.0k 1.1×	1.3k 1.5×	890 1.2×	806 1.2×	69	5.7k
Paolo Guarnieri United States	20	3.0k 1.1×	1.6k 1.8×	1.0k 1.2×	692 1.0×	1.1k 1.7×	31	5.8k
Willeke van Roon‐Mom Netherlands	39	2.8k 1.1×	547 0.6×	2.1k 2.4×	797 1.1×	249 0.4×	109	4.6k
Axel Methner Germany	37	2.4k 0.9×	369 0.4×	914 1.0×	110 0.2×	527 0.8×	87	4.4k

Countries citing papers authored by Sergey A. Krupenko

Since Specialization

Citations

This map shows the geographic impact of Sergey A. Krupenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey A. Krupenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey A. Krupenko more than expected).

Fields of papers citing papers by Sergey A. Krupenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey A. Krupenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey A. Krupenko. The network helps show where Sergey A. Krupenko may publish in the future.

Co-authorship network of co-authors of Sergey A. Krupenko

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey A. Krupenko. A scholar is included among the top collaborators of Sergey A. Krupenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey A. Krupenko. Sergey A. Krupenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

You, Mikyoung, Hanan E. Shamseldin, Blake R. Rushing, et al.. (2024). Further delineation of the phenotypic and metabolomic profile of ALDH1L2‐related neurodevelopmental disorder. Clinical Genetics. 105(5). 488–498. 1 indexed citations

Douillet, Christelle, Peter H. Cable, Sergey A. Krupenko, et al.. (2024). Metabolism of inorganic arsenic in mice carrying the human AS3MT gene and fed folate deficient or folate supplemented diet. Toxicology and Applied Pharmacology. 495. 117173–117173.

Miller, Brandi, Wencheng Li, Sergey A. Krupenko, et al.. (2023). Distinct inflammatory Th17 subsets emerge in autoimmunity and infection. The Journal of Experimental Medicine. 220(10). 16 indexed citations

Coleman, Michael F., Ciara H. O’Flanagan, Xuewen Chen, et al.. (2021). Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction. Nutrients. 13(5). 1637–1637. 9 indexed citations

Krupenko, Natalia I., Jaspreet Sharma, Peter Pediaditakis, et al.. (2020). Aldh1l2 knockout mouse metabolomics links the loss of the mitochondrial folate enzyme to deregulation of a lipid metabolism observed in rare human disorder. Human Genomics. 14(1). 41–41. 20 indexed citations

Sarret, Catherine, Zahra Ashkavand, Imen Dorboz, et al.. (2019). Deleterious mutations in ALDH1L2 suggest a novel cause for neuro-ichthyotic syndrome. npj Genomic Medicine. 4(1). 17–17. 15 indexed citations

Sharma, Jaspreet, Natalia I. Krupenko, & Sergey A. Krupenko. (2019). Impact of Aldh1l1 Knockout On Metabolic Phenotype in Mouse Liver. The FASEB Journal. 33(S1). 2 indexed citations

Fekry, Baharan, Kristen A. Jeffries, Amin Esmaeilniakooshkghazi, et al.. (2018). C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nature Communications. 9(1). 4149–4149. 81 indexed citations

Khan, Qasim A., Peter Pediaditakis, Amin Esmaeilniakooshkghazi, et al.. (2018). CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase. PLoS ONE. 13(7). e0199699–e0199699. 17 indexed citations

10.

Ashkavand, Zahra, Ciara H. O’Flanagan, M. Hennig, et al.. (2017). Metabolic Reprogramming by Folate Restriction Leads to a Less Aggressive Cancer Phenotype. Molecular Cancer Research. 15(2). 189–200. 36 indexed citations

11.

Horita, David A. & Sergey A. Krupenko. (2017). Modeling of interactions between functional domains of ALDH1L1. Chemico-Biological Interactions. 276. 23–30. 6 indexed citations

12.

Hoeferlin, L. Alexis, Baharan Fekry, Besim Öğretmen, Sergey A. Krupenko, & Natalia I. Krupenko. (2013). Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6. Journal of Biological Chemistry. 288(18). 12880–12890. 53 indexed citations

13.

Tsybovsky, Yaroslav & Sergey A. Krupenko. (2011). Conserved Catalytic Residues of the ALDH1L1 Aldehyde Dehydrogenase Domain Control Binding and Discharging of the Coenzyme. Journal of Biological Chemistry. 286(26). 23357–23367. 30 indexed citations

14.

Krupenko, Natalia I., et al.. (2010). ALDH1L2 Is the Mitochondrial Homolog of 10-Formyltetrahydrofolate Dehydrogenase. Journal of Biological Chemistry. 285(30). 23056–23063. 92 indexed citations

15.

Leclerc, Daniel, Liyuan Deng, Hana Friedman, et al.. (2008). Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice. Pharmacogenetics and Genomics. 18(7). 577–589. 15 indexed citations

16.

Oleinik, Natalia V., Natalia I. Krupenko, & Sergey A. Krupenko. (2007). Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene. 26(51). 7222–7230. 113 indexed citations

17.

Oleinik, Natalia V., Natalia I. Krupenko, David G. Priest, & Sergey A. Krupenko. (2005). Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochemical Journal. 391(3). 503–511. 37 indexed citations

18.

Oleinik, Natalia V. & Sergey A. Krupenko. (2003). Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis.. PubMed. 1(8). 577–88. 27 indexed citations

19.

Krupenko, Sergey A. & Natalia V. Oleinik. (2002). 10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells.. PubMed. 13(5). 227–36. 93 indexed citations

20.

Krupenko, Sergey A., Conrad Wagner, & Robert Cook. (1995). Cysteine 707 Is Involved in the Dehydrogenase Active Site of Rat 10-Formyltetrahydrofolate Dehydrogenase. Journal of Biological Chemistry. 270(2). 519–522. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact